R21 HL139934/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2016	1
2018	2
2019	2
2020	3
2021	3
2022	2
2023	1
2024	0

1

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor.

Jiang H, Fu D, Bidgoli A, Paczesny S. Jiang H, et al. Front Immunol. 2021 Oct 5;12:761448. doi: 10.3389/fimmu.2021.761448. eCollection 2021. Front Immunol. 2021. PMID: 34675938 Free PMC article. Review.

2

Biomarkers for posttransplantation outcomes.

Paczesny S. Paczesny S. Blood. 2018 May 17;131(20):2193-2204. doi: 10.1182/blood-2018-02-791509. Epub 2018 Apr 5. Blood. 2018. PMID: 29622549 Free PMC article. Review.

3

Biomarkers for Allogeneic HCT Outcomes.

Adom D, Rowan C, Adeniyan T, Yang J, Paczesny S. Adom D, et al. Front Immunol. 2020 Apr 21;11:673. doi: 10.3389/fimmu.2020.00673. eCollection 2020. Front Immunol. 2020. PMID: 32373125 Free PMC article. Review.

4

Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.

Bidgoli A, DePriest BP, Saatloo MV, Jiang H, Fu D, Paczesny S. Bidgoli A, et al. Transplant Cell Ther. 2022 Oct;28(10):657-666. doi: 10.1016/j.jtct.2022.07.008. Epub 2022 Jul 11. Transplant Cell Ther. 2022. PMID: 35830932 Free PMC article. Review.

5

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.

Logan BR, Fu D, Howard A, Fei M, Kou J, Little MR, Adom D, Mohamed FA, Blazar BR, Gafken PR, Paczesny S. Logan BR, et al. J Clin Invest. 2023 Aug 1;133(15):e168575. doi: 10.1172/JCI168575. J Clin Invest. 2023. PMID: 37526081 Free PMC article.

6

Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker.

Paczesny S. Paczesny S. Br J Haematol. 2021 Mar;192(6):951-967. doi: 10.1111/bjh.16497. Epub 2020 Feb 10. Br J Haematol. 2021. PMID: 32039480 Free PMC article. Review.

7

Clinical Proteomics for Post-Hematopoeitic Stem Cell Transplantation Outcomes.

Paczesny S, Metzger J. Paczesny S, et al. Proteomics Clin Appl. 2019 Mar;13(2):e1800145. doi: 10.1002/prca.201800145. Epub 2018 Oct 17. Proteomics Clin Appl. 2019. PMID: 30307119 Free PMC article. Review.

8

CXCL10: most consistent cGVHD biomarker?

Paczesny S, Abu Zaid M. Paczesny S, et al. Blood. 2016 Jun 16;127(24):2950-1. doi: 10.1182/blood-2016-04-709543. Blood. 2016. PMID: 27313326 Free PMC article.

9

An overview of multiplexed analyses of CAR T-cell therapies: insights and potential.

DePriest BP, Vieira N, Bidgoli A, Paczesny S. DePriest BP, et al. Expert Rev Proteomics. 2021 Sep;18(9):767-780. doi: 10.1080/14789450.2021.1992276. Epub 2021 Oct 17. Expert Rev Proteomics. 2021. PMID: 34628995 Free PMC article.

10

Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease.

DePriest BP, Li H, Bidgoli A, Onstad L, Couriel D, Lee SJ, Paczesny S. DePriest BP, et al. Blood Adv. 2022 May 24;6(10):2981-2986. doi: 10.1182/bloodadvances.2021005420. Blood Adv. 2022. PMID: 35030629 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year